News

Omaha doctor weighs in on FDA cracking down on some third party weight loss medications
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
FDA cracking down on Ozempic copycats, potentially slimming options for consumers
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...
FDA halts sale of off-brand Ozempic and other GLP-1 drugs
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
Futurism on MSN13h
Novo Nordisk Offering Large Discount on Wegovy in Bid to Recapture Market
It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.
STAT5d
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
NJBIZ11d
Frier Levitt to host webinar on GLP-1 legal risks
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
From insulin to Ozempic, history of Novo Nordisk's CEOs
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...